CLINICAL TRIAL / IRB25-0034

A Phase 2 Randomized, Double Blind, Placebo Controlled, Dose Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis, PVT 2201 203